Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.

Reem A Mubjer; Ahmed A Adeel; Michael Chance; Amir Hassan

doi:10.1186/1475-2875-10-245

Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.

Reem A Mubjer
, Ahmed A Adeel
, Michael Chance
, Amir Hassan

Liverpool School of Tropical Medicine

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Abstract

This is the first study to report baseline information on the characteristics and implications of anti-malarial drug resistance markers in Yemen. It is also the first report of the haplotype associated with CQR P. falciparum parasites from Yemen. Mutant pfcrtT76 is highly prevalent but it is a poor predictor of treatment failure in the study population. The prevalence of mutation dhfrArg59 is suggestive of emerging resistance to SP, which is currently a component of the recommended combination treatment of falciparum malaria in Yemen. More studies on these markers are recommended for surveillance of resistance in the study area.

Original language	English
Article number	245
Pages (from-to)	245
Journal	Malaria Journal
Volume	10
DOIs	https://doi.org/10.1186/1475-2875-10-245
Publication status	Published - 21 Aug 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/1475-2875-10-245Licence: CC BY

Chance-Malaria J-2011Final published version, 315 KBLicence: CC BY

Cite this

@article{2eee5dc95dd94a858d31d30f880f730c,

title = "Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.",

abstract = "This is the first study to report baseline information on the characteristics and implications of anti-malarial drug resistance markers in Yemen. It is also the first report of the haplotype associated with CQR P. falciparum parasites from Yemen. Mutant pfcrtT76 is highly prevalent but it is a poor predictor of treatment failure in the study population. The prevalence of mutation dhfrArg59 is suggestive of emerging resistance to SP, which is currently a component of the recommended combination treatment of falciparum malaria in Yemen. More studies on these markers are recommended for surveillance of resistance in the study area.",

author = "Mubjer, \{Reem A\} and Adeel, \{Ahmed A\} and Michael Chance and Amir Hassan",

year = "2011",

month = aug,

day = "21",

doi = "10.1186/1475-2875-10-245",

language = "English",

volume = "10",

pages = "245",

journal = "Malaria Journal",

issn = "1475-2875",

publisher = "BioMed Central Ltd",

}

TY - JOUR

T1 - Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.

AU - Mubjer, Reem A

AU - Adeel, Ahmed A

AU - Chance, Michael

AU - Hassan, Amir

PY - 2011/8/21

Y1 - 2011/8/21

N2 - This is the first study to report baseline information on the characteristics and implications of anti-malarial drug resistance markers in Yemen. It is also the first report of the haplotype associated with CQR P. falciparum parasites from Yemen. Mutant pfcrtT76 is highly prevalent but it is a poor predictor of treatment failure in the study population. The prevalence of mutation dhfrArg59 is suggestive of emerging resistance to SP, which is currently a component of the recommended combination treatment of falciparum malaria in Yemen. More studies on these markers are recommended for surveillance of resistance in the study area.

AB - This is the first study to report baseline information on the characteristics and implications of anti-malarial drug resistance markers in Yemen. It is also the first report of the haplotype associated with CQR P. falciparum parasites from Yemen. Mutant pfcrtT76 is highly prevalent but it is a poor predictor of treatment failure in the study population. The prevalence of mutation dhfrArg59 is suggestive of emerging resistance to SP, which is currently a component of the recommended combination treatment of falciparum malaria in Yemen. More studies on these markers are recommended for surveillance of resistance in the study area.

U2 - 10.1186/1475-2875-10-245

DO - 10.1186/1475-2875-10-245

M3 - Article

SN - 1475-2875

VL - 10

SP - 245

JO - Malaria Journal

JF - Malaria Journal

M1 - 245

ER -

Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this